© ۱۳۹۳
کلیه حقوق این سایت متعلق به ستاد توسعه فناوری نانو می باشد و هر گونه استفاده از مطالب آن بدون ذکر نام منبع ممنوع است.
نانو
nano
پيشوندي به معناي يک بيليونم يا (000،000،000،1/1). در متون فناورينانو، معمولا براي مشخص کردن يک واحد اندازهگيري برابر با 10 به توان منفي 9 متر استفاده ميشود.
لیپوزوم و کاربرد آنها در دارورسانی (2)
نمایش توضیحات فیلم
منابـــع و مراجــــع
1. http://www.roshd.ir/Default.aspx?tabid=442&EntryID=1681&SSOReturnPage=Check&Rand=0, 2012/7/4.
2. Peer, D., et al., Nanocarriers as an emerging platform for cancer therapy. Nat Nano, 2007. 2(12): p. 751-760.
3. Wu, G., et al., Chapter 14 Synthesis, Characterization, and Optical Response of Gold Nanoshells Used to Trigger Release from Liposomes, in Methods in Enzymology, D. Nejat, Editor. 2009, Academic Press. p. 279-307.
4. Anderson, L.J.E., et al., Optically guided controlled release from liposomes with tunable plasmonic nanobubbles. Journal of Controlled Release, 2010. 144(2): p. 151-158.
5. Liu, Z., et al., siRNA Delivery into Human T Cells and Primary Cells with Carbon-Nanotube Transporters. Angewandte Chemie International Edition, 2007. 46(12): p. 2023-2027.
6. Désormeaux, A. and M.G. Bergeron, Liposomes as Drug Delivery System: A Strategic Approach for the Treatment of HIV Infection. Journal of Drug Targeting, 1998. 6(1): p. 1-15.
7. Steger, L.D. and R.J. Desnick, Enzyme therapy VI: Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1977. 464(3): p. 530-546.
8. Finkelstein, M. and G. Weissmann, The introduction of enzymes into cells by means of liposomes. J Lipid Res, 1978. 19(3): p. 289-303.
9. Kubo, T., et al., Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. International journal of oncology, 2000. 17(2): p. 309-315.
10. Minko, T., et al., New generation of liposomal drugs for cancer. Anti-cancer agents in medicinal chemistry, 2006. 6(6): p. 537-552.
11. Anaissie, E., et al., Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. European Journal of Clinical Microbiology & Infectious Diseases, 1991. 10(8): p. 665-668.
12. Date, A.A., M.D. Joshi, and V.B. Patravale, Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Advanced Drug Delivery Reviews, 2007. 59(6): p. 505-521.
13. Alving, C.R., Liposomes as drug carriers in leishmaniasis and malaria. Parasitology Today, 1986. 2(4): p. 101-107.
14. Alving, C.R., et al., Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs. Proceedings of the National Academy of Sciences, 1978. 75(6): p. 2959-2963.
15. Drulis-Kawa, Z. and A. Dorotkiewicz-Jach, Liposomes as delivery systems for antibiotics. International Journal of Pharmaceutics, 2010. 387(1–2): p. 187-198.
16. Kilian, G., et al., Antimicrobial activity of liposome encapsulated cyclo(L-tyrosyl-L-prolyl). Pharmazie, 2011. 66(6): p. 421-3.
17. Barani, H., et al., Synthesis of Ag-liposome nano composites. Journal of Liposome Research, 2010. 20(4): p. 323-329.
18. Malcher, M., et al., Embedded Silver Ions-Containing Liposomes in Polyelectrolyte Multilayers: Cargos Films for Antibacterial Agents. Langmuir, 2008. 24(18): p. 10209-10215.
19. Li, C.Q., et al., Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J Gastroenterol, 2005. 11(3): p. 426-8.
20. Gilbert, B.E. and V. Knight, Pulmonary delivery of antiviral drugs in liposome aerosols. Seminars in Pediatric Infectious Diseases, 1996. 7(2): p. 148-154.
21. Koff, W.C. and I.J. Fidler, The potential use of liposome-mediated antiviral therapy. Antiviral Research, 1985. 5(3): p. 179-190.
22. Pollock, S., et al., N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. AIDS, 2008. 22(15).
23. Logue, C.H., et al., Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge. Antiviral Res, 2010. 87(2): p. 195-203.
24. Mannino, R.J. and S. Gould-Fogerite, Liposome mediated gene transfer. BioTechniques, 1988. 6(7): p. 682-690.
25. Straubinger, R.M. and D. Papahadjopoulos, [32] Liposomes as carriers for intracellular delivery of nucleic acids, in Methods in Enzymology, L.G.K.M. Ray Wu, Editor. 1983, Academic Press. p. 512-527.
26. Nicolau, C., A. Legrand, and E. Grosse, [16] Liposomes as carriers for in vivo gene transfer and expression, in Methods in Enzymology, K.J.W. Ralph Green, Editor. 1987, Academic Press. p. 157-176.
27. Madeira, C., et al., Nonviral Gene Delivery to Mesenchymal Stem Cells Using Cationic Liposomes for Gene and Cell Therapy. Journal of Biomedicine and Biotechnology, 2010. 2010.
28. Lee, E.M., et al., Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor. J Cancer Res Clin Oncol, 2004. 130(3): p. 169-77.
29. Fujii, Y., et al., Transfer of gene to human retinal pigment epithelial cells using magnetite cationic liposomes. British Journal of Ophthalmology, 2010. 94(8): p. 1074-1077.
30. Malone, R.W., P.L. Felgner, and I.M. Verma, Cationic liposome-mediated RNA transfection. Proceedings of the National Academy of Sciences, 1989. 86(16): p. 6077-6081.
31. Kinet, V., et al., Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth. Cancer Letters, 2009. 284(2): p. 222-228.
32. Williams, L.E., R.T. Proffitt, and L. Lovisatti, Possible applications of phospholipid vesicles (liposomes) in diagnostic radiology. J Nucl Med Allied Sci, 1984. 28(1): p. 35-45.
33. Presant, C.A., et al., Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer, 1988. 62(5): p. 905-911.
34. Dong, L., et al., Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice. Vaccine, 2012. 30(2): p. 254-264.
35. Bernstein, D.I., et al., Potent Adjuvant Activity of Cationic Liposome-DNA Complexes for Genital Herpes Vaccines. Clinical and Vaccine Immunology, 2009. 16(5): p. 699-705.
36. Christensen, D., et al., Liposome-based cationic adjuvant formulations (CAF): Past, present, and future. Journal of Liposome Research, 2009. 19(1): p. 2-11.
37. Tiwari, S., et al., Liposome in situ gelling system: Novel carrier based vaccine adjuvant for intranasal delivery of recombinant protein vaccine. Procedia in Vaccinology, 2009. 1(1): p. 148-163.
38. Christensen, D., et al., Cationic liposomes as vaccine adjuvants. Expert Review of Vaccines, 2011. 10(4): p. 513-521.
39. Niesman, M.R., The use of liposomes as drug carriers in ophthalmology. Critical reviews in therapeutic drug carrier systems, 1992. 9(1): p. 1-38.
40. Singh, K. and M. Mezei, Liposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfate. International Journal of Pharmaceutics, 1984. 19(3): p. 263-269.
41. Singh, K. and M. Mezei, Liposomal ophthalmic drug delivery system I. Triamcinolone acetonide. International Journal of Pharmaceutics, 1983. 16(3): p. 339-344.
42. Ebrahim, S., G.A. Peyman, and P.J. Lee, Applications of Liposomes in Ophthalmology. Survey of Ophthalmology, 2005. 50(2): p. 167-182.
43. Zhang, L., et al., Nanoparticles in Medicine: Therapeutic Applications and Developments. Clin Pharmacol Ther, 2007. 83(5): p. 761-769.
44. Süleymanoglu, E., A NANOSCALE POLYNUCLEOTIDE-NEUTRAL LIPOSOME SELF-ASSEMBLIES FORMULATED FOR THERAPEUTIC GENE DELIVERY. Rev Electron Biomed / Electron J Biomed 2004(2): p. 13-35.
عنوان : لیپوزوم ها و فرایند حمل دارو و مواد آرایشی
توضیحات : لیپوزوم یک وزیکولمیکروسکوپی شامل دولایهی فسفولیپیدی است که یک فضای مائی را احاطه نموده است. ویژگی هایی ازقبیل سمیت ذاتی پایین،زیست تجزیه پذیری وفقدان ایمونوژنیسیته،سبب شده است که لیپوزوم هابه عنوان یک حامل بسیار مناسب درسیستم های دارورسانی نوین موردتوجه واقع شوند. این ساختارهای ریز و کیسه مانند، شبیه بسته ها یا کپسول هایی میباشند که می توان با بدام انداختن داروها در درونشان، از آنها برای حمل دارو و سایر مواد مثل مواد به نقاط مختلف بدن استفاده کرد.